What is Cornerstone Robotics?
Founded in 2019, Cornerstone Robotics (CSR) is at the forefront of medical innovation, specializing in surgical robotics and related technologies. The company is dedicated to making high-quality healthcare more accessible and efficient worldwide by developing cutting-edge robotic systems. CSR has cultivated a global team comprising experts in surgical robotics, clinical professionals, and multidisciplinary innovators, fostering rapid development across its key operational hubs in Hong Kong, Shenzhen, Beijing, Shanghai, London, and Portsmouth. The company's focus on advancing surgical care positions it as a key innovator in the medtech sector.
How much funding has Cornerstone Robotics raised?
Cornerstone Robotics has raised a total of $348.3M across 3 funding rounds:
Series B
$78.3M
Series C
$70M
Other Financing Round
$200M
Series B (2021): $78.3M with participation from New World, Eli Lilly, Meituan, and Gaorong Capital
Series C (2025): $70M led by ITVF - Innovation and Technology Venture Fund, Qiming Venture Partners, eGarden, EQT, and Alpha JWC Ventures
Other Financing Round (2025): $200M supported by Qiming Venture Partners and Gaorong Capital
Key Investors in Cornerstone Robotics
Qiming Venture Partners
Qiming Venture Partners is a prominent venture capital firm focusing on technology, healthcare, and AI, known for supporting innovative startups with strategic guidance and resources to achieve significant growth.
Eli Lilly
Eli Lilly and Company is a global biopharmaceutical firm dedicated to the discovery, development, and commercialization of prescription medicines, with a strong emphasis on areas like diabetes, oncology, and immunology.
New World
New World Development Company Limited is a diversified Hong Kong-based property group with extensive investments in residential, retail, office, and hospitality assets, alongside a broad range of related services.
What's next for Cornerstone Robotics?
The recent enterprise-level funding and strategic investment indicate that Cornerstone Robotics is likely in a significant scaling phase, potentially preparing for broader market penetration or the development of next-generation surgical platforms. This capital infusion will likely be directed towards expanding its global operational footprint, accelerating research and development initiatives, and strengthening its market position against competitors. The company's trajectory suggests a strong focus on commercialization and further solidifying its role as a leader in the surgical robotics industry, aiming to capture a larger share of the global healthcare technology market.
See full Cornerstone Robotics company page
